Cc1c(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CCCC(O)C4)c(F)c32)c(=O)n(-c2ccccc2)n1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?